Variant report
Variant | esv3371273 |
---|---|
Chromosome Location | chr10:25636346-25640744 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:25606928..25608702-chr10:25636326..25639003,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11816375 | chr10:25636376-25636377 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs554789768 | chr10:25636405-25636406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138383580 | chr10:25636409-25636410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1760755 | chr10:25636415-25636416 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs1773651 | chr10:25636425-25636426 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs182519473 | chr10:25636428-25636429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199719224 | chr10:25636429-25636430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1760757 | chr10:25636438-25636439 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs143891427 | chr10:25636492-25636493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544463591 | chr10:25636501-25636502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561556367 | chr10:25636518-25636519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530254507 | chr10:25636566-25636567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150219379 | chr10:25636578-25636579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566582714 | chr10:25636729-25636730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138691566 | chr10:25636745-25636746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187224908 | chr10:25636746-25636747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569166670 | chr10:25636784-25636785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111227766 | chr10:25636796-25636797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143385554 | chr10:25636798-25636799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190661993 | chr10:25636826-25636827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10450325 | chr10:25636849-25636850 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs149354695 | chr10:25636918-25636919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144831320 | chr10:25636943-25636944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373728474 | chr10:25636965-25636966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553382454 | chr10:25636966-25636967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375656949 | chr10:25636982-25636983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546286897 | chr10:25637053-25637054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1760758 | chr10:25637069-25637070 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs558562706 | chr10:25637174-25637175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575509310 | chr10:25637185-25637186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182736761 | chr10:25637217-25637218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1760759 | chr10:25637243-25637244 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs10508692 | chr10:25637270-25637271 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs568698460 | chr10:25637284-25637285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540473942 | chr10:25637319-25637320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370728953 | chr10:25637326-25637327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs3220916 | chr10:25637327-25637328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142269031 | chr10:25637335-25637336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34088676 | chr10:25637365-25637366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369945614 | chr10:25637401-25637402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139773985 | chr10:25637452-25637453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74123864 | chr10:25637491-25637492 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs187719214 | chr10:25637492-25637493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571456196 | chr10:25637506-25637507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111505083 | chr10:25637527-25637528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2807255 | chr10:25637528-25637529 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs548422589 | chr10:25637536-25637537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568265203 | chr10:25637549-25637550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74123865 | chr10:25637599-25637600 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs7915893 | chr10:25637606-25637607 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 21439084 | CNVD |
Maculopathy | 20981449 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:25632400-25642600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr10:25639200-25640200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr10:25639400-25639800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |